HPV and p53 in cervical cancer.
Open Access
- 1 June 1994
- journal article
- Published by BMJ in Sexually Transmitted Infections
- Vol. 70 (3), 167-170
- https://doi.org/10.1136/sti.70.3.167
Abstract
OBJECTIVE--To determine the prevalence of HPV 16 and 18 E6 by DNA detection and p53 abnormal protein expression in cervical cancers in Hong Kong. MATERIALS AND METHODS--Seventy-three squamous cell cervical cancer biopsy were analysed. Detection of HPV DNA was carried out by the polymerase chain reaction and Southern blotting (PCR/SB) technique using primers to the HPV16 & 18 E6 region and consensus primers to the L1 region. Abnormal expression of the p53 protein was detected by immunohistochemical staining (IHS) using the antibody CM1 on frozen sections of 55 cervical cancer samples. Forty-six samples were analysed for both the presence of HPV DNA and abnormal expression of p53. RESULTS--67.2% of the 64 samples showed the presence of HPV 16 E6 DNA and 39.1% showed the presence of HPV 18 E6 DNA. 32.8% showed the presence of both HPV 16 and 18 E6 DNA. No HPV DNA was shown in 10.9% of samples. Only 3.6% (2) of 55 samples showed positive IHS with CM1. One occurred in a HPV negative sample and the other in a HPV positive sample. CONCLUSION--A high prevalence of HPV DNA was detected in cervical cancer in Hong Kong using the PCR/SB technique. However, abnormal expression of p53 was uncommon amongst patients with or without HPV 16 or 18 infection.Keywords
This publication has 19 references indexed in Scilit:
- The causal link between human papillomavirus and invasive cervical cancer: A population‐based case‐control study in colombia and spainInternational Journal of Cancer, 1992
- Human Papillomavirus and Its Prognostic Significance in Invasive Carcinoma of the Cervix in Young PatientsInternational Journal of Gynecological Pathology, 1992
- Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumoursThe Lancet, 1992
- Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activationCell, 1991
- Human papillomaviruses in the pathogenesis of anogenital cancerVirology, 1991
- The p53 tumour suppressor geneNature, 1991
- Search for human papillomavirus, herpes simplex virus and c-myc oncogene in human genital tumorsInternational Journal of Cancer, 1989
- The Human Papilloma Virus-16 E7 Oncoprotein Is Able to Bind to the Retinoblastoma Gene ProductScience, 1989
- The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection.BMJ, 1989
- 3-Aminopropyltriethoxysilane (APES): a new advance in section adhesion.Journal of Clinical Pathology, 1987